The Neuropsychological Dimensions of Postinfectious Neuromyasthenia (Chronic Fatigue Syndrome): A Preliminary Report

Abstract

Postinfectious neuromyasthenia (PIN) is a clinical syndrome of protracted and incomplete recovery after an apparent viral-like illness. Medical investigation yields few abnormalities which might account for the symptomatology. A substantial number of PIN patients complain of cognitive changes. Specific complaints include impaired attention, concentration and abstraction skills. This study was designed to systematically investigate whether the aforementioned subjective complaints could be quantified objectively using standard neuropsychological instruments. Results indicated that on all tests but one, the subjects' performances were significantly higher than those of their age matched groups in the normative data. Specifically, PIN patients scored significantly better than their age matched norms on tests of concentration, attention and abstraction. What is most striking is the discrepancy between the subjective complaints of cognitive impairment and the objective results of the subjects' performances on all tests. These findings suggest that psychological factors may play an important role in the cognitive functioning of individuals diagnosed with postinfectious neuromyasthenia.

Keywords

postinfectious post-viral neuromyasthenia chronic fatigue syndrome neuropsychology cognitive impairment

Get full access to this article

View all access options for this article.

References

Salit

I. E.

, Sporadic Post-Infectious Neuromyasthenia: Persistent Illness after Acute Infection, Canadian Medical Association Journal, 133, pp. 659–663, 1985.

Buchwald

Sullivan

J. L.

, and Komaroff

A. L.

, Frequency of “Chronic Active Epstein—Barr Virus Infection” in a General Medical Practice, Journal of the American Medical Association, 257, pp. 2303–2307, 1987.

Holmes

G. P.

Kaplan

J. E.

Gantz

N. M.

Komaroff

A. L.

Schnonberger

L. B.

, Chronic Fatigue Syndrome: A Working Case Definition, Annals of Internal Medicine, 108, pp. 387–389, 1988.

Straus

S. E.

, The Chronic Mononucleosis Syndrome, Journal of Infectious Diseases, 157, pp. 405–412, 1988.

Dubois

R. E.

Seeley

J. K.

, Chronic Mononucleosis Syndrome, Southern Medical Journal, 77, pp. 1376–1382, 1984.

Jones

J. F.

and Miller

B. D.

, The Post-viral Asthenia Syndrome, in Viruses Immunity and Mental Disorders, Kurstak

Lipowski

, and Morozov

P. V.

(eds.), Plenum Publishers, New York, 1987.

Crowelyn

Nelson

, and Stoving

, Epidemiological Aspects of Outbreak of Encephalomyelitis at Hospital in Summer of 1955, Royal Free Journal of Hygiene, 55, pp. 102–122, 1957.

Johnson

, Journey into Fear: The Growing Nightmare of EBV, Rolling Stone, 505, p. 56, 1987.

Jones

J. F.

Ray

, Evidence for Active Epstein—Barr Virus Infection in Patients with Persistent Unexplained Illnesses: Elevated Anti-Early Antigen Antibodies, Annals of Internal Medicine, 102, pp. 1–7, 1985.

10.

Kruesi

M. J. P.

Dale

, and Straus

S. E.

, Psychiatric Diagnoses in Patients Who Have Chronic Fatigue Syndrome, Journal of Clinical Psychiatry, 50: 2, pp. 53–56, 1989.

11.

Lezak

M. D.

, Neuropsychological Assessment, 2nd Edition, Oxford University Press, New York, 1983.

12.

Davies

, The Influence of Age on Trail Making Test Performance, Journal of Clinical Psychology, 24, pp. 96–98, 1968.

13.

Wechsler

, Manual for the Wechsler Adult Intelligence Scale—Revised, Psychological Corporation, New York, 1981.

14.

Paulson

M. J.

and Lin

, Predicting WAIS IQ from Shipley—Hartford Scores, Journal of Clinical Psychology, 26, pp. 453–461, 1970.

15.

Zackary

R. A.

, Shipley Institute of Living Scale: Revised Manual, Western Psychological Services, Los Angeles, 1987.

16.

Zackary

R. A.

Crumpton

, and Speigel

D. E.

, Estimating WAIS-R IQ from the Shipley Institute of Living Scale, Journal of Clinical Psychology, 41, pp. 532–541, 1985.

17.

Straus

S. E.

, Persisting Illness and Fatigue in Adults with Evidence of Epstein—Barr Virus Infection, Annals of Internal Medicine, 102, pp. 7–16, 1985.

18.

Taerk

G. S.

Toner

B. B.

Salit

I. E.

Garfinkel

P. E.

, and Ozersky

, Depression in Patients with Neuromyasthenia (Benign Myalgic Encephalomyelitis), International Journal of Psychiatry in Medicine, 17, pp. 49–55, 1987.

19.

Riggs

and Katon

, Chronic Epstein—Barr Virus Syndrome: Relationship to Psychiatric Diagnosis, Abstract, American Psychiatric Association 141st Annual Meeting Syllabus, p. 114, 1988.

20.

Abbey

S. E.

, Depression and Chronic Fatigue Syndrome: Cause, Effect or Covariate, to be published as part of the proceedings of the NIH/University of Pittsburgh Conference Considerations in the “Design of Studies of Chronic Fatigue Syndrome,” September, 1988.

21.

Segal

Z. V.

and Shaw

B. F.

, Cognition in Depression: A Reappraisal of Coyne and Gotlib's Critique, Cognitive Therapy and Research, 10, pp. 671–693, 1986.